Active pharmaceutical ingredient (API) characterization is a cornerstone of drug development, ensuring the identity, purity, stability, and performance of therapeutic compounds. We specialize in delivering rigorous analytical solutions to support API development, from early-stage research to commercialization. Our expertise in Small Molecule API design and API Process Research and Development enables us to address complex challenges in physicochemical profiling, structural elucidation, and regulatory compliance.
Note: This service is for research use only and not intended for clinical use.
Overview of API Characterization
API characterization involves a systematic evaluation of physical, chemical, and biological properties to establish critical quality attributes (CQAs). These attributes influence drug solubility, bioavailability, stability, and manufacturability. Comprehensive characterization is essential for regulatory filings (e.g., ICH Q6A, Q11) and ensures batch-to-batch consistency. Key parameters include crystallinity, particle morphology, hygroscopicity, and impurity profiles. By identifying and controlling these variables, we mitigate risks in formulation development and scale-up, ultimately accelerating time-to-market for novel therapies.
Our Services
API Crystallinity and Polymorphism
We employ X-ray diffraction (XRD) and thermal analysis to identify polymorphic forms and assess their thermodynamic stability. Understanding polymorphism is critical for avoiding unexpected phase transitions during manufacturing or storage.
API Particle Size and Morphology
Laser diffraction and microscopy techniques quantify particle size distribution and shape, which directly impact dissolution rates, blend uniformity, and tablet compressibility.
Dynamic vapor sorption (DVS) studies evaluate moisture uptake, guiding packaging and storage conditions to prevent degradation.
Bulk and tapped density measurements, coupled with powder rheology, optimize flow properties for efficient processing in solid dosage forms.
Differential scanning calorimetry (DSC) and isothermal titration calorimetry (ITC) characterize melting points, enthalpy changes, and binding interactions.
High-performance liquid chromatography (HPLC), mass spectrometry (MS), and nuclear magnetic resonance (NMR) detect and quantify impurities down to ppm levels, ensuring compliance with ICH guidelines.
API Solubility and Partition Coefficient
Shake-flask methods and computational modeling determine logP/logD values, informing formulation strategies for poorly soluble compounds.
API Molecular Weight and Molecular Formula
Mass spectrometry and elemental analysis confirm molecular integrity, supporting regulatory submissions.
Fourier-transform infrared (FTIR) spectroscopy and Raman spectroscopy identify functional groups, verifying synthesis pathways.
Forced degradation studies under stress conditions (heat, light, pH) predict stability and degradation pathways.
Long-term and accelerated stability testing under ICH conditions (25°C/60% RH, 40°C/75% RH) establish shelf-life and storage recommendations.
Our Technologies and Methods
Our advanced laboratory is equipped with state-of-the-art technologies to deliver precise and reliable results. Our methodologies are validated and align with international regulatory standards, ensuring that the data we provide supports your product development goals.
- X-ray Powder Diffraction (XRPD): Determines crystalline structures and detects polymorphic forms, critical for ensuring consistency and bioavailability.
- DSC: Analyzes thermal properties like melting points and glass transitions, informing processing parameters.
- Laser Diffraction Particle Size Analysis: Provides accurate particle size distribution measurements, essential for optimizing dissolution rates.
- HPLC: Offers sensitive detection and quantification of impurities and confirmation of purity levels.
- MS: Enables precise molecular weight determination and structural analysis for confirming API identity.
- FTIR: Identifies functional groups and characterizes molecular bonding, aiding in reactivity assessments.
- Thermogravimetric Analysis (TGA): Measures changes in weight in relation to temperature, important for assessing hygroscopicity and thermal stability.
- NMR Spectroscopy: Provides detailed molecular structure information, essential for comprehensive API characterization.
Frequently Asked Questions
Q1: Why is analyzing API polymorphism crucial for my pharmaceutical development project?
API polymorphism can significantly impact a drug's solubility, stability, and bioavailability. By identifying and controlling polymorphic forms, we help ensure consistent therapeutic performance and avoid issues related to variable absorption rates.
Q2: How does particle size affect the efficacy of my pharmaceutical product?
Particle size influences the dissolution rate and, consequently, the bioavailability of the API. Optimizing particle size and morphology enhances drug absorption and ensures consistent dosing, which is critical for therapeutic effectiveness.